medigraphic.com
ISSN 1817-5996 (Electronic)

2013, Number 2

<< Back Next >>

Rev Cub de Reu 2013; 15 (2)

Immune System and pregnancy: topics in both healthy women and rheumatic patients

Torres LAM, Hernández CMV, Rodríguez TAY

Language: Spanish
References: 36
Page:
PDF size: 236.94 Kb.


ABSTRACT

Immune system’s tolerance to semi-allogenic antigens during pregnancy is a particular case of response, very efficient in order to maintain the safety of binomius mother/foetus. In this review we emphasizes in those immunological and hormone mechanisms which are involved in tolerance to pregnancy. We also focus in patients with rheumatic autoimmune diseases, in which immunological tolerance mechanisms are broken as part of the pathogenesis of their diseases, whose pregnancies could ameliorate or worsened their conditions, and which recommendations would be usefully for these patients in order to have healthy pregnancy and babies.


REFERENCES

  1. Munoz-Suano A, Hamilton A. B, Betz A. G. Gimme shelter: the immune system during pregnancy. Immunol Rev. 241: 20–38.

  2. Guleria I, Sayegh M.H. Maternal Acceptance of the Fetus: True Human Tolerance. J. Immunol. 2007:178 (6): 3345-51.

  3. Shyi-Jou C, Yung-Liang L, Huey-Kang S. Immunologic Regulation in Pregnancy: From Mechanism to Therapeutic Strategy for Immunomodulation. Clin Devel Immunol .2012: 258391, 10.

  4. Burt TD. Fetal regulatory T cells and peripheral immune tolerance in utero: implications for development and disease. Am J Reprod Immunol . 2013;69(4):346-58.

  5. Erlebacher A. Mechanisms of T cell tolerance towards the allogeneic fetus. Nat Rev Immunol .2001;(1):13, 23-33.

  6. Kumpel B. M, Manoussaka M. S. Placental immunology and maternal alloimmune responses. V Sang. 2012; 102,(1):2- 12.

  7. Von Rango U. Fetal tolerance in human pregnancy--a crucial balance between acceptance and limitation of trophoblast invasion. Immunol Lett. 2008;115(1):21-32.

  8. Doria A, Iaccarino L, Arienti S. Th2 immune deviation induced by pregnancy: the two faces of autoimmune rheumatic diseases. Reprod toxicol. 2006;22(2):234-41.

  9. Bordon Y: Reproductive immunology: Hormonal support for regulatory T cells. Nat Rev Immunol. 2013;13:156

  10. Ostensen M, Förger F, Villiger PM: Cytokines and pregnancy in rheumatic disease. Ann N Y Acad Sci. 2006;(6) 1069:353-63.

  11. VarshaJ .and Caroline G. Managing pregnancy in inflammatory rheumatological diseases. Arth Res Ther. 2011,13:206.

  12. Ostensen M., Brucato A., Carp H., Chambers C., Radboud J. E., Doria A.,Gordon C. et.al. Pregnancy and reproduction in autoinmune rheumatic diseases. Rheumatol. 2011;50:657-64.

  13. Gayed M., Gordon C. Pregnancy and rheumatic diseases .Rheumatol 2009 ;46:1634–1640.

  14. Cutolo M, Capellino S, Straub RH. Estrogens in rheumatic diseases: friend or foe? Rheumatoloy. 2008; Suppl 3(47):2-5.

  15. Buyon JP, Petri MA, Kim MY. The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann Intern Med. 2005;142:953-62.

  16. Petri M, Kim MY, Kalunian KC. Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med. 2005;353:2550-8.

  17. Ostensen M, Villiger PM. The remission of rheumatoid arthritis during pregnancy. Semin Immunopathol.2007;29:185-191.

  18. De Man YA, Dolhain RJEM, van de Geijn FE, Willemsen SP, Hazes JMW. Disease activity of rheumatoid arthritis during pregnancy. Results from a nationwide prospective study. Arthritis Rheum. 2008;59:1241-8.

  19. Doria A, Ghirardello A, Iaccarino L. Pregnancy, cytokines and disease activity in systemic lupus erythematosus. Arthritis Rheum. 2004;51:989-95.

  20. Ostensen M. New insights into sexual functioning and fertility in rheumatic diseases. Best Pract Res Clin Rheumatol. 2004;18:219-32.

  21. Su KY, Pisetsky DS. The role of extracellular DNA in autoimmunity in SLE. Scand J Immunol. 2009;70:175-83.

  22. Kanda N, Tsuchida T, Tamaki K. Estrogen enhancement of anti-double-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Arthritis Rheum. 1999;42:328-37.

  23. Bernier MO, Mikaeloff Y, Hudson M, Suissa S. Combined oral contraceptive use and the risk of systemic lupus erythematosus. Arthritis Rheum. 2009;61:476-81.

  24. Ruiz-Irastorza G, Khamashta MA. Lupus and pregnancy: ten questions and some answers. Lupus. 2008;17:416-20.

  25. Merino-Ibarra E., Delgado Beltrán C. Artritis reumatoide: ¿cómo usar los fármacos en el embarazo y la lactancia?_ Reumatol Clin. 2011;7(4):262-66.

  26. de Man YA, Bakker-Jonges LE, Dufour-van den Goorbergh.. Women with rheumatoid arthritis negative for anti-CCP and rheumatoid factor are more likely to improve during pregnancy, whereas in autoantibody positive women autoantibody levels are not influenced by pregnancy. Ann Rheum Dis. 2010;69:420-3.

  27. Yan Z, Lambert NC, Ostensen M, Adams KM, Guthrie KA, Nelson JL. Prospective study of fetal DNA in serum and disease activity during pregnancy in women withinflammatory arthritis. Arthritis Rheum. 2006;54:2069-73.

  28. Rak JM, Maestroni L, Balandraud N. Transfer of the shared epitope through microchimerism in women with rheumatoid arthritis. Arthritis Rheum. 2009; 60:73-80.

  29. Forger F, Marcoli N, Gadola S, Moller B, Villiger PM, Ostensen M. Pregnancy induces numerical and functional changes of CD4+CD25high regulatory T cells in patients with rheumatoid arthritis. Ann Rheum Dis. 2008;67:984-90.

  30. Clowse ME, Magder LS, Witter F, Petri M. Early risk factors for pregnancy loss in lupus. Obstet Gynecol. 2006; 107:293-9.

  31. Salmon J, Kim MY, Rana S. Angiogenic factor imbalance in pregnant SLE patients may explain increased risk for complications. Arthritis Rheum. 2009;60 :655.

  32. Brucato A, Doria A, Frassi M. Pregnancy outcome in 100 women with autoimmune diseases and anti-Ro/SSA antibodies: a prospective controlled study. Lupus. 2002;11 :203-11.

  33. Sebire NJ, Backos M, El Gaddal S, Goldin RD, Regan L. Placental pathology, antiphospholipid antibodies, and pregnancy outcome in recurrent miscarriage patients. Obstet Gynecol. 2003;101: 258-63.

  34. Erkan D, Patel S, Nuzzo M. Management of the controversial aspects of the antiphospholipid syndrome pregnancies: a guide for clinicians and researchers. Rheumatology. 2008;Suppl 3(47):23-7.

  35. Rotar Z, Rozman B, de Groot PG. Sixth meeting of the European Forum on antiphospholipid antibodies. How to improve the understanding of the antiphospholipid syndrome? Lupus. 2009;18 :53-60.

  36. Doria A, Bajocchi G, Tonon M, Salvarani C. Pre-pregnancy counselling of patients with vasculitis. Rheumatology. 2008; Suppl 3(47): 3-5




2020     |     www.medigraphic.com